All Stories

  1. DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
  2. Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV
  3. Effects of Nutrients on Platelet Function: A Modifiable Link between Metabolic Syndrome and Neurodegeneration?
  4. Nutrition to Optimise Human Health—How to Obtain Physiological Substantiation?
  5. Positive effects of folic acid supplementation on cognitive aging are dependent on ω-3 fatty acid status: a post hoc analysis of the FACIT trial
  6. Levels of Inflammation Markers Are Associated with the Risk of Recurrence and All-Cause Mortality in Patients with Colorectal Cancer
  7. A 2 Week Cross-over Intervention with a Low Carbohydrate, High Fat Diet Compared to a High Carbohydrate Diet Attenuates Exercise-Induced Cortisol Response, but Not the Reduction of Exercise Capacity, in Recreational Athletes
  8. Inflammation Is a Mediating Factor in the Association between Lifestyle and Fatigue in Colorectal Cancer Patients
  9. Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis
  10. Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
  11. Drug use is associated with lower plasma magnesium levels in geriatric outpatients; possible clinical relevance
  12. Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages
  13. A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice
  14. The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation
  15. N-Eicosapentaenoyl Dopamine, A Conjugate of Dopamine and Eicosapentaenoic Acid (EPA), Exerts Anti-inflammatory Properties in Mouse and Human Macrophages
  16. Anti-inflammatory nutrition with high protein attenuates cardiac and skeletal muscle alterations in a pulmonary arterial hypertension model
  17. The Effect of Calcium Buffering and Calcium Sensor Type on the Sensitivity of an Array-Based Bitter Receptor Screening Assay
  18. Feeding mitochondria: Potential role of nutritional components to improve critical illness convalescence
  19. Ionized and Total Magnesium Levels Change during Repeated Exercise in Older Adults
  20. Identification of hydroxytyrosyl oleate, a derivative of hydroxytyrosol with anti-inflammatory properties, in olive oil by-products
  21. Capsaicin Analogues Derived from n-3 Polyunsaturated Fatty Acids (PUFAs) Reduce Inflammatory Activity of Macrophages and Stimulate Insulin Secretion by β-Cells In Vitro
  22. Mitochondrial dynamics in cancer-induced cachexia
  23. Let thy food be thy medicine….when possible
  24. Release of Major Peanut Allergens from Their Matrix under Various pH and Simulated Saliva Conditions—Ara h2 and Ara h6 Are Readily Bio-Accessible
  25. Plasma citrulline concentration, a marker for intestinal functionality, reflects exercise intensity in healthy young men
  26. Changes in iron metabolism during prolonged repeated walking exercise in middle-aged men and women
  27. In Vitro Anti-Inflammatory and Radical Scavenging Properties of Chinotto (Citrus myrtifolia Raf.) Essential Oils
  28. Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
  29. Associations of hyperosmolar medications administered via nasogastric or nasoduodenal tubes and feeding adequacy, food intolerance and gastrointestinal complications amongst critically ill patients: A retrospective study
  30. Calcium Imaging of GPCR Activation Using Arrays of Reverse Transfected HEK293 Cells in a Microfluidic System
  31. The role of fatty acids and their endocannabinoid-like derivatives in the molecular regulation of appetite
  32. Docosahexaenoyl serotonin emerges as most potent inhibitor of IL-17 and CCL-20 released by blood mononuclear cells from a series of N -acyl serotonins identified in human intestinal tissue
  33. The role of hypothalamic inflammation, the hypothalamic–pituitary–adrenal axis and serotonin in the cancer anorexia–cachexia syndrome
  34. Public health relevance of drug–nutrition interactions
  35. Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis
  36. Decrease in Ionized and Total Magnesium Blood Concentrations in Endurance Athletes Following an Exercise Bout Restores within Hours—Potential Consequences for Monitoring and Supplementation
  37. Optimal nutrition and the ever-changing dietary landscape: a conference report
  38. Fish oil LC-PUFAs do not affect blood coagulation parameters and bleeding manifestations: Analysis of 8 clinical studies with selected patient groups on omega-3-enriched medical nutrition
  39. Micronutrient Intakes in 553 Dutch Elite and Sub-Elite Athletes: Prevalence of Low and High Intakes in Users and Non-Users of Nutritional Supplements
  40. Macronutrient Intakes in 553 Dutch Elite and Sub-Elite Endurance, Team, and Strength Athletes: Does Intake Differ between Sport Disciplines?
  41. Nutritional Supplement Use by Dutch Elite and Sub-Elite Athletes: Does Receiving Dietary Counseling Make a Difference?
  42. Endurance Exercise Increases Intestinal Uptake of the Peanut Allergen Ara h 6 after Peanut Consumption in Humans
  43. CYP2C9 Genotypes Modify Benzodiazepine-Related Fall Risk: Original Results From Three Studies With Meta-Analysis
  44. Detection of peanut allergen in human blood after consumption of peanuts is skewed by endogenous immunoglobulins
  45. Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans
  46. Drug-Nutrition Interactions in Older People
  47. Adaptation of exercise-induced stress in well-trained healthy young men
  48. N-Docosahexaenoyl Dopamine, an Endocannabinoid-like Conjugate of Dopamine and the n-3 Fatty Acid Docosahexaenoic Acid, Attenuates Lipopolysaccharide-Induced Activation of Microglia and Macrophages via COX-2
  49. Molecule formed in gut from n-3 fatty acid DHA and serotonin may be beneficial in attenuating IBD
  50. Moderate alcohol consumption after a mental stressor attenuates the endocrine stress response
  51. The Noncaloric Sweetener Rebaudioside A Stimulates Glucagon-Like Peptide 1 Release and Increases Enteroendocrine Cell Numbers in 2-Dimensional Mouse Organoids Derived from Different Locations of the Intestine
  52. The effect of endurance exercise on intestinal integrity in well-trained healthy men
  53. Fatty acids, endocannabinoids and inflammation
  54. Self-Reported Use and Reasons among the General Population for Using Sports Nutrition Products and Dietary Supplements
  55. Nutrient-induced glucagon like peptide-1 release is modulated by serotonin
  56. Increased hypothalamic serotonin turnover in inflammation-induced anorexia
  57. Hypothalamic inflammation and food intake regulation during chronic illness
  58. Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
  59. Analysis of Omega-3 Fatty Acid Derived N-Acylethanolamines in Biological Matrices
  60. Intraileal casein infusion increases plasma concentrations of amino acids in humans: A randomized cross over trial
  61. The effects of a meal with moderate alcohol consumption on mood and autonomic nervous system balance
  62. Validation of web-based, multiple 24-h recalls combined with nutritional supplement intake questionnaires against nitrogen excretions to determine protein intake in Dutch elite athletes
  63. Vitamin D, Inflammation, and Colorectal Cancer Progression: A Review of Mechanistic Studies and Future Directions for Epidemiological Studies
  64. Nutrient Intake by Ultramarathon Runners: Can They Meet Recommendations?
  65. Moderate alcohol consumption stimulates food intake and food reward of savoury foods
  66. Effects of Mood Inductions by Meal Ambiance and Moderate Alcohol Consumption on Endocannabinoids and N-Acylethanolamines in Humans: A Randomized Crossover Trial
  67. Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice
  68. Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling
  69. Cholecystokinin regulates satiation independently of the abdominal vagal nerve in a pig model of total subdiaphragmatic vagotomy
  70. Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer's Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
  71. Omega-3 Polyunsaturated N-Acylethanolamines: A Link Between Diet and Cellular Biology
  72. Contributors
  73. Medication-Related Fall Incidents in an Older, Ambulant Population: The B-PROOF Study
  74. Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoidN-docosahexaenoylethanolamine (DHEA) in macrophages
  75. Cross-Species Comparison of Genes Related to Nutrient Sensing Mechanisms Expressed along the Intestine
  76. Steviol Glycoside Rebaudioside A Induces Glucagon-like Peptide-1 and Peptide YY Release in a Porcine ex Vivo Intestinal Model
  77. Associations Between Medication Use and Homocysteine Levels in an Older Population, and Potential Mediation by Vitamin B12 and Folate: Data from the B-PROOF Study
  78. The endocannabinoid system and appetite: relevance for food reward
  79. The endocannabinoid system
  80. The Biphasic Effects of Moderate Alcohol Consumption with a Meal on Ambiance-Induced Mood and Autonomic Nervous System Balance: A Randomized Crossover Trial
  81. The Association Between Drugs Frequently Used by the Elderly and Vitamin D Blood Levels: A Review of Observational and Experimental Studies
  82. Palmitoylethanolamide (PEA)—‘Promiscuous’ anti-inflammatory and analgesic molecule at the interface between nutrition and pharma
  83. The Endocannabinoid System: A Dynamic Signalling System at the Crossroads Between Metabolism and Disease
  84. Hypothalamic food intake regulation in a cancer-cachectic mouse model
  85. Comparative analyses of seeds of wild fruits of Rubus and Sambucus species from Southern Italy: Fatty acid composition of the oil, total phenolic content, antioxidant and anti-inflammatory properties of the methanolic extracts
  86. Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients
  87. N-acyl amines of docosahexaenoic acid and othern-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leads
  88. The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not Receiving Antiretroviral Therapy (The BITE Study)
  89. Measurement of Palmitoylethanolamide and Other N-Acylethanolamines During Physiological and Pathological Conditions
  90. Liquid chromatography–tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells
  91. Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold
  92. Vitamin D: do we get enough?
  93. Effects of Long- and Short-Chain Fatty Acids on the Release of Gastrointestinal Hormones using an ex Vivo Porcine Intestinal Tissue Model
  94. Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum and adipose tissue in C57BL/6 mice fed a fish-oil diet
  95. Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues
  96. Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice
  97. Moderate alcohol consumption alters both leucocyte gene expression profiles and circulating proteins related to immune response and lipid metabolism in men
  98. A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance
  99. Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract
  100. 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: Evidence-based nutrition
  101. Alterations in total and high–molecular-weight adiponectin after 3 weeks of moderate alcohol consumption in premenopausal women
  102. Bovine Colostrum Supplementation’s Lack of Effect on Immune Variables during Short-Term Intense Exercise in Well-Trained Athletes
  103. The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: evidence for a new link between fish oil and inflammation
  104. Pharma–nutrition interface: The gap is narrowing
  105. Voeding en geneesmiddelen
  106. Current and Future Drug Targets in Weight Management
  107. Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties
  108. Short-term oral exposure to white wine transiently lowers serum free fatty acids
  109. The role of epoxidation and electrophile-responsive element-regulated gene transcription in the potentially beneficial and harmful effects of the coffee components cafestol and kahweol☆
  110. Use of Animal Models of Disease in the Preclinical Safety Evaluation of Biopharmaceuticals
  111. ChemInform Abstract: Selective Synthesis of Unsaturated N-Acylethanolamines by Lipase-Catalyzed N-Acylation of Ethanolamine with Unsaturated Fatty Acids.
  112. Absorption, Distribution, and Biliary Excretion of Cafestol, a Potent Cholesterol-Elevating Compound in Unfiltered Coffees, in Mice
  113. Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women
  114. Biologically Active Compounds in Food Products and Their Effects on Obesity and Diabetes
  115. Selective Synthesis of Unsaturated N-Acylethanolamines by Lipase- Catalyzed N-Acylation of Ethanolamine with Unsaturated Fatty Acids
  116. Xanthohumol from Hop (Humulus lupulus L.) Is an Efficient Inhibitor of Monocyte Chemoattractant Protein-1 and Tumor Necrosis Factor-α Release in LPS-Stimulated RAW 264.7 Mouse Macrophages and U937 Human Monocytes
  117. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography–tandem mass spectrometry
  118. Contributor contact details
  119. Commentary: “A systems view on the future of medicine: Inspiration from Chinese medicine?”
  120. Herbal products: Marketing strategies and legislation
  121. Food–Drug Interactions in Older People
  122. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways
  123. Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages
  124. In Search of Secreted Protein Biomarkers for the Anti-inflammatory Effect of β 2 -Adrenergic Receptor Agonists:  Application of DIGE Technology in Combination with Multivariate and Univariate Data Analysis Tools
  125. Inhibitory effects of the beta2-adrenergic receptor agonist zilpaterol on the LPS-induced production of TNF-alpha in vitro and in vivo
  126. Genomics and systems biology - how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
  127. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology
  128. Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis
  129. Multi-detector computed tomography and 3-dimensional imaging in a multi-vendor picture archiving and communications systems (PACS) environment1
  130. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line
  131. Endotoxin-induced liver damage in rats is minimized by � 2 -adrenoceptor stimulation
  132. TRANSFER OF POLYCHLORINATED BIPHENYLS AND CHLORINATED PESTICIDES FROM MOTHER TO PUP IN RELATION TO CYTOCHROME P450 ENZYME ACTIVITIES IN HARP SEALS (PHOCA GROENLANDICA) FROM THE GULF OF ST. LAWRENCE, CANADA
  133. Transfer of polychlorinated biphenyls and chlorinated pesticides from mother to pup in relation to cytochrome P450 enzyme activities in harp seals (Phoca groenlandica) from the Gulf of St. Lawrence, Canada
  134. Development of an Androgen Reporter Gene Assay (AR-LUX) Utilizing a Human Cell Line with an Endogenously Regulated Androgen Receptor
  135. Differential effects of pentoxifylline on the hepatic inflammatory response in porcine liver cell cultures
  136. Direct cell-to-cell contact between Kupffer cells and hepatocytes augments endotoxin-induced hepatic injury
  137. The preparation, solubilisation and binding characteristics of a β2-adrenoceptor isolated from transfected Chinese hamster cells
  138. Stereoselectivity at the β 2 -adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of β 2 -agonists
  139. Chlorinated pesticide concentrations, with an emphasis on polychlorinated camphenes (toxaphenes), in relation to cytochrome P450 enzyme activities in harp seals (Phoca groenlandica) from the Barents Sea
  140. Cocultures of porcine hepatocytes and kupffer cells as an improvedin vitromodel for the study of hepatotoxic compounds
  141. Cytochromes and cytokines: Changes in drug disposition in animals during an acute phase response: A mini‐review
  142. Suppression of the acute inflammatory response of porcine alveolar‐ and liver macrophages
  143. The β-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-α and IL-6 in vitro and in vivo
  144. Cytochrome P450-mediated enzyme activities and polychlorinated biphenyl accumulation in harp seal (Phoca groenlandica)
  145. 17α-Ethyl-5β-estrane-3α,17β-diol, a biological marker for the abuse of norethandrolone and ethylestrenol in slaughter cattle
  146. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle
  147. Participation of β-Adrenergic Receptors on Macrophages in Modulation of LPS-Induced Cytokine Release
  148. Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes
  149. Phase I and phase II enzyme activities in Ringed seals (Phoca hispida): characterization of hepatic cytochrome P450 by activity patterns, inhibition studies, mRNA analyses, and western blotting
  150. Dose and time dependency of cytochrome P4501A induction in liver and kidney of B(a)P exposed Arctic charr (Salvelinus alpinus)
  151. Congener specific PCB and polychlorinated camphene (toxaphene) levels in Svalbard ringed seals (Phoca hispida) in relation to sex, age, condition and cytochrome P450 enzyme activity
  152. Identification of some important metabolites of boldenone in urine and feces of cattle by gas chromatography-mass spectrometry†
  153. Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calves†
  154. Comparison of conventional immunoassays and the oestrogen radioreceptor assay for screening for the presence of oestrogenic anabolic compounds in urine samples†
  155. In vitro liver models are important tools to monitor the abuse of anabolic steroids in cattle†
  156. The effect of sulfaphenazole and sulfadoxine on tolbutamide disposition in dwarf goats (Caprus hircus aegagrus)
  157. Isolation of a bovine full length cytochrome P450 (CYP3A) cDNA sequence and its functional expression in V79 cells
  158. Differential inhibitory effects of phenytoin, diclofenac, phenylbutazone and a series of sulfonam ides on hepatic cytochrom e P4502C activityin vitro, and correlation with som e m olecular descriptors in the dwarf goat (Caprus hircus aegagrus).
  159. Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome p450
  160. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism
  161. Time-dependent induction of two distinct hepatic cytochrome P4501A catalytic activities at low temperatures in Arctic charr (Salvelinus alpinus) after oral exposure to benzo(a)pyrene
  162. Cytochrome P4502E in vivo and in vitro in the dwarf goat: effects of enzyme induction and the applicability of chlorzoxazone as marker substrate
  163. Suppression of Cytochrome P450- and UDP Glucuronosyl Transferase-Dependent Enzyme Activities by Proinflammatory Cytokines and Possible Role of Nitric Oxide in Primary Cultures of Pig Hepatocytes
  164. Inhibition of tolbutamide 4-methylhydroxylation by a series of non-steroidal anti-inflammatory drugs in V79-NH cells expressing human cytochrome P4502C10
  165. Gender differences in ethanol oxidation and cytochrome P4502E1 content and functions in hepatic microsomes from alcohol-preferring and non-preferring rats
  166. In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): Substrate activities and effects of inducers
  167. Tiamulin inhibits human CYP3A4 activity in an NIH/3T3 cell line stably expressing CYP3A4 cDNA
  168. Oral bioavailability of sulphonamides in ruminants: A comparison between sulphamethoxazole, sulphatroxazole, and sulphamerazine, using the dwarf goat as animal model
  169. Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats
  170. Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig
  171. Tiamulin selectively inhibits oxidative hepatic steroid and drug metabolism in vitro in the pig
  172. The Pig as a Model for Studying AH Receptor and Other PAH-Binding Proteins In Man
  173. Oral bioavailability of sulphamethoxydiazine, sulphathiazole and sulphamoxole in dwarf goats
  174. Dose-dependent pharmacokinetic interaction between antipyrine and paracetamolin vivoandin vitrowhen administered as a cocktail in pig
  175. Selective changes in oxidative xenobiotic metabolism in vivo and in vitro after parenteral administration of recombinant bovine somatotrophin to rats
  176. Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in the dwarf goat
  177. Hormonal regulation of oxidative drug metabolism in the dwarf goat. The effect of sex and hormonal treatment on plasma disposition and metabolite formation of sulphadimidine
  178. The regulation of oxidative drug metabolism by growth hormone in the dwarf goat: differences from and similarities to the mechanisms in rats
  179. Regioselective O-demethylation of scoparone (6,7-dimethoxycoumarin) to assess cytochrome P450 activities in vitro in rat. Effects of gonadal steroids and the involvement of constitutive P450 enzymes
  180. Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin
  181. High-performance liquid chromatographic method for the routine determination of sulphadimidine, its hydroxy metabolites and N4-acetylsulphadimidine in body fluids and cell culture media
  182. Species- and sex-related differences in the plasma clearance and metabolite formation of antipyrine. A comparative study in four animal species: Cattle, goat, rat and rabbit
  183. The influence of gender and gonadal hormones on the plasma clearance and metabolite formation of antipyrine in ruminants
  184. Has bovine somatotropin (BST) an effect upon drug disposition? Comparative studies in goats and cattle with sulphadimidine and antipyrine after parenteral administration of BST, zeranol and proligestone
  185. Use of Animal Models of Disease in the Preclinical Safety Evaluation of Biopharmaceuticals